Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Stock
Equities
GENIL
TREGENL00024
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.45 TRY | -1.09% | +6.28% | +35.35% |
Sales 2022 | 5.45B 168M | Sales 2023 | 8.15B 252M | Capitalization | 14.06B 434M |
---|---|---|---|---|---|
Net income 2022 | 1.08B 33.35M | Net income 2023 | 455M 14.05M | EV / Sales 2022 | 2.76 x |
Net cash position 2022 | 494M 15.26M | Net Debt 2023 | 594M 18.34M | EV / Sales 2023 | 1.8 x |
P/E ratio 2022 |
14.4
x | P/E ratio 2023 |
30.9
x | Employees | 622 |
Yield 2022 |
2.15% | Yield 2023 |
-
| Free-Float | 25.82% |
1 day | -1.09% | ||
1 week | +6.28% | ||
Current month | +4.96% | ||
1 month | +11.12% | ||
3 months | -16.35% | ||
6 months | +19.15% | ||
Current year | +35.35% |
Managers | Title | Age | Since |
---|---|---|---|
Nadir Ulu
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-30 |
Ali Ketencioglu
IRC | Investor Relations Contact | - | 21-08-31 |
Sales & Marketing | - | 10-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abidin Gulmus
CHM | Chairman | - | - |
Sukru Turkmen
BRD | Director/Board Member | - | - |
Ömer Dinçer
BRD | Director/Board Member | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 63.45 | -1.09% | 1,218,216 |
24-06-07 | 64.15 | +2.80% | 1,794,661 |
24-06-06 | 62.4 | +2.13% | 1,517,172 |
24-06-05 | 61.1 | -0.65% | 2,267,405 |
24-06-04 | 61.5 | +3.02% | 1,812,000 |
Delayed Quote Borsa Istanbul, June 10, 2024 at 11:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+35.35% | 588M | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- GENIL Stock